Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for Subacute Pulmonary Dysfunction Following Allogeneic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation- Netherlands

doi 10.1016/j.bbmt.2011.11.031

Full Text

Abstract

Available in

Categories

Transplantation

Date

July 1, 2012

Authors

Gregory A. Yanik

Carrie L. Kitko

Mark T. Vander Lugt

Andrew C. Harris

Kenneth R. Cooke

Publisher

Elsevier BV

Related search

Pulmonary Tuberculosis in Allogeneic Hematopoietic Stem Cell Transplantation

Bone Marrow Transplantation

Transplantation

English

Chimerism Monitoring Following Allogeneic Hematopoietic Stem Cell Transplantation

Bone Marrow Transplantation

Transplantation

English

Rapamycin-Induced Proteinuria Following Allogeneic Hematopoietic Stem Cell Transplantation

Bone Marrow Transplantation

Transplantation

English

Central Nervous System (CNS) Tuberculosis Following Allogeneic Stem Cell Transplantation

Bone Marrow Transplantation

Transplantation

English

Changes in Salivary Proteome Following Allogeneic Hematopoietic Stem Cell Transplantation

Experimental Hematology

Cancer Research

Molecular Biology

English

Cytomegalovirus Viremia Is a Risk Factor for Late-Onset Hemorrhagic Cystitis Following Allogeneic Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation

Transplantation

English

Allogeneic Stem Cell Transplantation for Sickle Cell Disease

Current Opinion in Hematology

English

Targets of Tumor Immunity After Allogeneic Hematopoietic Stem Cell Transplantation

Clinical Cancer Research

Cancer Research

English

CrmE, a Novel Soluble Tumor Necrosis Factor Receptor Encoded by Poxviruses

Journal of Virology

English